Clinical Trials Directory

Trials / Completed

CompletedNCT03218722

Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma

Impact of Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
350 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute traumatic coagulopathy (ATC) is common in severe trauma patients (around 25 to 30% of patients with severe trauma) and is associated with increased mortality. ATC is associated with fibrinogen and clotting factors deficiencies. Therefore, ATC management relies on early administration of fibrinogen and blood products in case of massive transfusion with a 1:1 or 1:2 ratio between Fresh Frozen Plasma (FFP) and Red Blood Cells (RBC). This strategy relies on fast supply of FFP. To overcome delay for FFP ordering, transport and defrosting, the PROCOAG study proposes to use prothrombrin concentrate complex (PCC) as alternative to treat coagulation factor deficiency. PCC is readily available upon hospital arrival. In addition to fibrinogen treatment, it is thought that PCC can be efficient in ATC management, while reducing risks associated with massive transfusion. ProCoag is a randomized, controlled, double-blinded, parallel clinical trial aiming at showing superiority of early PPC+ fibrinogen strategy on fibrinogen only strategy for the management of patients at risk of massive transfusion. Early administration of PPC should optimize patient blood management and therefore reduce blood products transfused within the first 24 hours following a severe trauma.

Conditions

Interventions

TypeNameDescription
DRUGPro-Thrombin Concentrate ComplexPatient at risk of massive hemorrhage will be managed with standard care with 1ml/kg PCC.
DRUGNaCl 0.9%Patient at risk of massive hemorrhage will be managed with standard care with 1ml/kg Saline solution.

Timeline

Start date
2017-12-29
Primary completion
2021-08-31
Completion
2022-06-15
First posted
2017-07-14
Last updated
2022-11-08

Locations

12 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03218722. Inclusion in this directory is not an endorsement.